Introducing: The STDtector

A low-cost HIV diagnostic device for the developing world designed by Biomedical and Materials Science Engineering Students at the University of California, Irvine.

The Problem

Why HIV?

The Human Immunodeficiency Virus (HIV) is a lentivirus that attacks immune cells called CD4 T-cells. When the level of CD4 drops below 200 cells per cubic millimeter of blood, the HIV infection becomes categorized as Acquired Immunodeficiency Syndrome (AIDS). By this point, the body becomes highly susceptible to various infections and without treatment, the individual would have only about 3 years to live. As of currently there is no cure, however the treatment of HIV can easily prevent its progression and extend the lifespan of the infected individual. Hence, the need and the ability to provide for early detection and diagnosis of HIV is crucial.

HIV is known to be a global epidemic, of which, has claimed 35 million lives, thus far. As of currently, there are still about 33 million people worldwide living with some degree of HIV/AIDS. About 67% of these individuals reside in Sub-Saharan Africa alone. Ironically, the means of HIV detection are especially limited in developing countries like Sub-Saharan Africa due to factors like cost and availability. Standard Point of Care involves accurate, but highly costly laboratory testing whereas Rapid Point of Care is cheap and quick, but lack in accuracy.

Prevalence of HIV around the world

Solution: The STDtector

Purpose

The purpose of this project is to address the limitations placed upon the expense and availability of HIV detection in the clinics and non-laboratory environments of developing countries by developing a portable HIV diagnostic device that can bridge the technologies of HIV-antibody detection and microfluidic technology while taking into account minimal resources and affordability.

Features

The STDtector consists of a reagent cartridge, a gp-41 antigen-bound microfluidic chip, and an optical detector with linear stage.

Tests cost as low as $0.50 USD.

Receive results in as little as 20 minutes.

Does not require laboratory environment, only medical expert.

Uses Indirect ELISA to detect gp-41 antibodies using a gp-41 antigen-bound microfluidic chip.

As simple as injecting supplied reagents into microfluidic chip and loading onto the optical detector platform.






Our Products

Notice: As of currently, we are still in the midst of qualification testing. However, we are planning on targeting our device towards hospitals and clinics in developing countries. If you are a representative who is interested in our device, please feel free to send us an inquiry below.

Card image

STDtector Starter Kit

The STDtector Starter Kit includes one Reusable Optical Detector Unit with 50 Disposable Microfluidic Chip & Reagent Cartridge Tests.

$120.00 USD

Card image

STDtector Refills Kit

The STDtector Refills Kit includes 100 Disposable Microfluidic Chip & Reagent Cartridge Tests.


$50.00 USD

Card image

STDtector Optical Detector

The STDtector Optical Detector includes only one Reusable Optical Detector Unit.



$90.00 USD




The Market

Diagnostic Devices Market

In 2017, the STD diagnostic market value was about $2.7 Billion, and it is projected to reach over $5 Billion by 2024 (Allied Market Research).

Target Consumers

As our device requires some laboratory expertise, we aim to market our device towards hospitals and clinics in developing countries.

Our device will be portable and lightweight enough for the user to use in a small local village clinic (or non-laboratory setting) so that the sample would not have to be shipped far away. By not having to transport the sample, travel fees and risks (EG: deterioration or misplacement of the sample) would be significantly relieved when taking into account the fact that there are developing countries like Africa where there is only a single doctor for every 5000 civilians.

Our Competitors

Notice: Please hover over logos to learn more.
Avatar

Alere HIV-1/2 Ag/Ab Combo Test ($34.00 USD/test)

Results in 20 to 30 minutes, Unavailable in Developing Countries, Medium Accuracy (In-Lab ELISA w/ Blood)

>
Avatar

Oraquick In-Home HIV Test ($39.99 USD/test)

Results in <20 minutes, Unavailable in Developing Countries, Low-Medium Accuracy (In-Home ELISA w/ Saliva)

>
Avatar

Nucleic Acid Test ($100+ USD/test)

Results in 1 day to 2 weeks, Requires Laboratory Expert and Environment, High Accuracy (Nucleic Acid)

>



Meet Our Team

Image

Jennifer Luong (Team Lead)

Research & Development

Fourth year Biomedical Engineering student with a specialization in Biophotonics.

Image

Chris Zhang

Research & Development

Fourth year Biomedical Engineering student with a specialization in Micro/Nano.

Image

Jeremy Jacinto

Prototype & Manufacture

Fourth year Biomedical Engineering student with a specialization in Micro/Nano.

Image

Angel Ravelo

Prototype & Manufacture

Fourth year Mechanical Engineering and Materials Science Engineering student.

Image

Henry Hoang

Quality Assurance

Fourth year Biomedical Engineering student with a specialization in Micro/Nano.

Image

Adam Park

Quality Assurance

Fourth year Materials Science Engineering student.

Image

William Tang

Faculty Advisor

Professor in Biomedical Engineering with a focus on Micro/Nano.

Image

Maryam Shakib

Engineering Mentor

Software Test Engineer at Applied Medical.

Our Company

Image

STDtector Diagnostics

A group of 6 Biomedical and Materials Science Engineering Students at the University of California, Irvine currently designing and testing a low-cost HIV diagnostic device for the developing world's hospitals and clinics.

Together, we can prolong the lives of others.

Our vision is to be able to see families living healthy and united as one, where no one is seen as an outcast because of what they have.

In the near future, we are hoping to include additional microfluidic channels on a single chip and implement our device towards detection of other sexually transmitted diseases.

Our mission is to make detection and diagnosis of Sexually Transmitted Diseases, such as HIV, more accessible by providing hospitals and clinics of the developing world with a low-cost STD diagnostic device.

By providing an easily accessible mode of detection, affected individuals would be able to receive the earliest treatment possible to control the virus and live a normal life.

Contact Us

Get In Touch!

Come Visit Us!


Our Affiliates